Original Article
Oncogene (2007) 26, 4979–4986; doi:10.1038/sj.onc.1210299; published online 19 February 2007
Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen
D Bubman1, I Guasparri2 and E Cesarman3
- 1Department of Pathology and Laboratory Medicine, Weill Graduate School of Medical Sciences of Cornell University, New York, NY, USA
- 2Department of Pathology and Laboratory Medicine, Weill Graduate School of Medical Sciences of Cornell University, New York, NY, USA
- 3Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY, USA
Correspondence: Associate Professor E Cesarman, Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, 1300 York Ave, Room C410, New York, NY, USA. E-mail: ecesarm@med.cornell.edu
Received 17 June 2006; Revised 12 August 2006; Accepted 12 August 2006; Published online 19 February 2007.
Abstract
Primary effusion lymphoma (PEL) is a rare subtype of non-Hodgkin's lymphoma, which is associated with infection by Kaposi's sarcoma herpesvirus (KSHV)/human herpesvirus-8. The c-Myc transcription factor plays an important role in cellular proliferation, differentiation and apoptosis. Lymphomas frequently have deregulated c-Myc expression owing to chromosomal translocations, amplifications or abnormal stabilization. However, no structural abnormalities were found in the c-myc oncogene in PEL. Given that c-Myc is often involved in lymphomagenesis, we hypothesized that it is deregulated in PEL. We report that PEL cells have abnormally stable c-Myc protein. The turnover of c-Myc protein is stringently regulated by post-transcriptional modifications, including phosphorylation of c-Myc threonine 58 (T58) by glycogen synthase kinase-3
(GSK-3
). Our data show that the impaired c-Myc degradation in PEL cells is associated with a significant underphosphorylation of c-Myc T58. The KSHV latency-associated nuclear antigen (LANA) is responsible for this deregulation. Overexpression of LANA in human embryonic kidney 293 or peripheral blood B cells leads to post-transcriptional deregulation of c-Myc protein. Conversely, when LANA is eliminated from PEL cells using RNA interference, GSK-3
-mediated c-Myc T58 phosphorylation is restored. The presence of c-Myc and LANA in GSK-3
-containing complexes in PEL cells further confirms the significance of these interactions in naturally KSHV-infected cells.
Keywords:
KSHV, HHV-8, PEL, c-Myc, LANA
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
NEWS AND VIEWS
Kaposi virus scores cancer coup
Nature Medicine News and Views (01 Mar 2003)
Seeking the cause of Kaposi's sarcoma
Nature Medicine News and Views (01 Aug 1996)
RESEARCH
Oncogene Original Article
Nature Medicine Article (01 Mar 2003)
